Switch to Raltegravir Decreases Soluble CD14 in Virologically Suppressed Overweight Women: The Women, Integrase, and Fat Accumulation Trial

OBJECTIVES: Soluble CD14 (sCD14) is a monocyte activation marker associated with increased mortality in HIV. We assessed 48-week changes in sCD14 and other inflammatory biomarkers in virologically suppressed, HIV-infected women switching to raltegravir (RAL) from PI or NNRTI. METHODS: HIV-infected w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lake, Jordan E., McComsey, Grace A., Hulgan, Todd, Wanke, Christine A., Mangili, Alexandra, Walmsley, Sharon L., Stramotas, Stephanie A., Tracy, Russell P., Currier, Judith S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4107004/
https://ncbi.nlm.nih.gov/pubmed/24506429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados